Clinical Trials Browser

Phase 1/2 × Pancreatic Cancer Non-resectable × Gemcitabine × Clear all

NCT07575191 2026-05-08

Safety and Performance of a Novel Infusion Catheter System for Peri/Intratumoral Gemcitabine Delivery in Patients With Pancreatic Cancer

Phase 1/2 Not yet recruiting

Gastrointestinal

Pancreatic Cancer Non-resectable